```html

Zoster‑Related Hearing Loss

What is Zoster‑Related Hearing Loss?

Zoster‑related hearing loss, also called herpes zoster oticus or Ramsay Hunt syndrome type II, occurs when the varicella‑zoster virus (VZV) that causes chicken‑pox reactivates in the facial nerve (cranial nerve VII) and the adjacent vestibulocochlear nerve (cranial nerve VIII). The virus can inflame the inner ear structures, leading to sudden sensorineural hearing loss, vertigo, tinnitus, and facial weakness.

Most cases develop after a painful rash appears on or around the ear (often called “shingles of the ear”). Even when the rash is mild or absent, the virus can still damage hearing. Early recognition is crucial because prompt antiviral therapy can improve hearing outcomes and reduce the risk of permanent disability.

Common Causes

While the direct cause is VZV reactivation, several factors increase the likelihood of developing zoster‑related hearing loss:

• Age ≥ 60 years – immune surveillance declines with age.
• Immunocompromised state – HIV infection, organ transplantation, chemotherapy, or long‑term corticosteroid use.
• Previous chicken‑pox infection – everyone who has had chicken‑pox carries latent VZV.
• Stress or severe illness – can trigger viral reactivation.
• Chronic ear disease – chronic otitis media may provide a route for viral spread.
• Diabetes mellitus – impairs cellular immunity.
• Autoimmune conditions – e.g., rheumatoid arthritis, systemic lupus.
• Radiation therapy to the head/neck – damages local immune cells.
• Trauma to the ear or facial nerve – may disrupt the nerve’s protective sheath.
• Genetic predisposition – certain HLA types are linked to higher VZV reactivation rates.

Associated Symptoms

Hearing loss rarely occurs in isolation. Typical accompanying features include:

• Ear pain (otalgia) – often severe and burning.
• Rash or vesicles on the ear canal, pinna, or in the mouth (Ramsay Hunt rash).
• Facial weakness or paralysis – drooping of one side of the face, difficulty closing the eye.
• Vertigo or disequilibrium – a sensation that the room is spinning.
• Tinnitus – ringing, buzzing, or hissing in the affected ear.
• Ear fullness or pressure.
• Nausea and vomiting – secondary to vertigo.
• Reduced taste sensation on the front two‑thirds of the tongue (due to facial nerve involvement).

When to See a Doctor

Prompt evaluation is essential. Seek medical care if you experience any of the following:

• Sudden hearing loss in one ear, especially if it occurs within 72 hours.
• Severe ear pain accompanied by a rash or blisters.
• Facial droop, difficulty closing the eye, or slurred speech.
• Vertigo that does not improve within a few hours.
• Persistent tinnitus or a feeling of ear fullness that lasts more than 24 hours.
• Any symptom that interferes with the ability to work, drive, or perform daily activities.

If you fall into any of these categories, contact an otolaryngologist (ENT specialist) or go to the nearest emergency department. Early antiviral treatment (ideally within 72 hours of symptom onset) dramatically improves hearing recovery odds.

Diagnosis

Diagnosis combines a detailed history, physical examination, and targeted testing.

History & Physical Exam

• Ask about recent shingles, ear pain, facial weakness, and immune status.
• Inspect the ear canal and outer ear for vesicular rash.
• Perform a cranial‑nerve examination, focusing on the facial nerve (House‑Brackmann grading).
• Balance assessment – Dix‑Hallpike maneuver if vertigo is present.

Audiologic Testing

• Pure‑tone audiometry – determines the degree and type (sensorineural vs. conductive) of hearing loss.
• Speech‑recognition scores – assess functional hearing.

Imaging

• Magnetic Resonance Imaging (MRI) with gadolinium – visualizes inflammation of the facial/vestibulocochlear nerves and excludes tumors or stroke.
• High‑resolution CT of the temporal bone – used when ossicular chain disease is suspected.

Laboratory Tests

• Polymerase chain reaction (PCR) of vesicular fluid or ear discharge for VZV DNA (highly specific).
• Serum VZV IgM/IgG titers – helpful when PCR is unavailable.

Additional Tests (selected cases)

• Vestibular‑evoked myogenic potentials (VEMP) to evaluate inner‑ear balance function.
• Electro‑cochleography (ECoG) if Ménière‑like symptoms are present.

Treatment Options

Therapy is multidimensional: antiviral medication, corticosteroids, symptom control, and supportive care.

Antiviral Therapy

• Acyclovir 800 mg 5 times daily, valacyclovir 1 g 3 times daily, or famciclovir 500 mg 3 times daily for 7–10 days.
• Start within 72 hours of symptom onset for maximal benefit (Mayo Clinic, 2023).
• IV acyclovir (10–15 mg/kg every 8 hours) may be required for severe cases or immunocompromised patients.

Corticosteroids

• Prednisone 1 mg/kg/day (max 60 mg) for 7 days, then taper over 5–7 days.
• Evidence from randomized trials shows combined antiviral + steroid therapy improves hearing recovery by ~15 % compared with antivirals alone (Cochrane Review, 2022).

Pain & Symptom Management

• Analgesics – acetaminophen or NSAIDs for mild‑moderate pain.
• Neuropathic pain agents (gabapentin, pregabalin) if pain is burning or persists after rash resolves.
• Antiemetics (ondansetron, prochlorperazine) for vertigo‑related nausea.
• Topical lidocaine drops for severe ear pain (use with caution; avoid if perforated tympanic membrane).

Physical Therapy & Rehabilitation

• Facial‑nerve rehabilitation – facial massage, gentle exercises, or biofeedback for patients with facial weakness.
• Vestibular rehabilitation therapy (VRT) to reduce dizziness and improve balance.
• Hearing rehabilitation – hearing aids or cochlear implants if permanent loss remains.

Home & Supportive Care

• Keep the affected ear dry; use a waterproof earplug while showering.
• Apply cool compresses to reduce pain and swelling.
• Maintain good hydration and a balanced diet to support immune recovery.
• Avoid smoking and excessive alcohol, which can impair healing.

Prevention Tips

Because zoster‑related hearing loss stems from VZV reactivation, prevention focuses on reducing the risk of shingles and maintaining overall ear health.

• Shingles vaccine – Recombinant zoster vaccine (Shingrix) is >90 % effective in adults ≥50 years; CDC recommends it even for immunocompetent adults with prior shingles.
• Stay up to date on routine immunizations (influenza, COVID‑19) that support general immunity.
• Control chronic conditions (diabetes, hypertension) with physician‑guided management.
• Practice good hand hygiene and avoid sharing items that may irritate the ear canal.
• Limit exposure to extreme temperature changes that could stress the ear.
• For immunocompromised patients, discuss prophylactic antivirals with a specialist.
• Reduce stress through regular exercise, mindfulness, or counseling.

Emergency Warning Signs

Key Take‑aways

• Zoster‑related hearing loss is a medical emergency; early antiviral and steroid therapy improves outcomes.
• Look for the classic triad: ear pain, vesicular rash, and facial weakness.
• Patients ≥60 years, immunocompromised individuals, and those with chronic illnesses are at highest risk.
• Vaccination with Shingrix is the most effective preventive measure.
• Never ignore sudden hearing loss—contact an ENT specialist within 24 hours.

References:

• Mayo Clinic. “Ramsay Hunt syndrome.” Updated 2023. https://www.mayoclinic.org
• CDC. “Shingles (Herpes Zoster) Vaccination.” 2024. https://www.cdc.gov
• NIH National Institute on Deafness and Other Communication Disorders. “Sudden Sensorineural Hearing Loss.” 2022.
• Cochrane Database of Systematic Reviews. “Antiviral and corticosteroid treatment for Ramsay Hunt syndrome.” 2022.
• World Health Organization. “Guidelines for the management of herpes zoster.” 2023.

```